Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Paganelli C, Majorana A, Gastaldi G, Bossi P, Berruti A, Pavanato G, Nicolai P, Maroldi R, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Among authors: berruti a. Crit Rev Oncol Hematol. 2016 Jan;97:131-42. doi: 10.1016/j.critrevonc.2015.08.010. Epub 2015 Aug 12. Crit Rev Oncol Hematol. 2016. PMID: 26318095 Review.
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance.
Grisanti S, Almici C, Consoli F, Buglione M, Verardi R, Bolzoni-Villaret A, Bianchetti A, Ciccarese C, Mangoni M, Ferrari L, Biti G, Marini M, Ferrari VD, Nicolai P, Magrini SM, Berruti A. Grisanti S, et al. Among authors: berruti a. PLoS One. 2014 Aug 8;9(8):e103918. doi: 10.1371/journal.pone.0103918. eCollection 2014. PLoS One. 2014. PMID: 25105871 Free PMC article.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Bossi P, Majorana A, Gastaldi G, Berruti A, Trippa F, Nicolai P, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Among authors: berruti a. Crit Rev Oncol Hematol. 2016 Jun;102:47-54. doi: 10.1016/j.critrevonc.2016.03.012. Epub 2016 Mar 11. Crit Rev Oncol Hematol. 2016. PMID: 27061883 Review.
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature.
Grisanti S, Ferrari VD, Buglione M, Agazzi GM, Liserre R, Poliani L, Buttolo L, Gipponi S, Pedersini R, Consoli F, Panciani P, Roca E, Spena G, Triggiani L, Berruti A; Gruppo Neuro-Oncologico Bresciano. Grisanti S, et al. Among authors: berruti a. J Neurosurg Sci. 2019 Aug;63(4):458-467. doi: 10.23736/S0390-5616.16.03874-1. Epub 2016 Sep 28. J Neurosurg Sci. 2019. PMID: 27680966
521 results